Effects of a Yeast Fermentate (EpiCor) Supplement on Cold or Flu Symptoms in Healthy Children
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if participants must stop taking their current medications, but it asks participants to maintain their current lifestyle habits, including medications, as much as possible.
Is there any safety data available for the treatment known as EpiCor, Placebo, Control, or Dummy Treatment?
Placebo treatments, often used as controls in clinical trials, have been studied for their safety and effectiveness across different diseases. However, reports on adverse events (unwanted side effects) in these trials are often incomplete or inconsistent, indicating a need for better reporting to fully understand their safety profile.12345
What is the purpose of this trial?
This trial tests if taking EpiCor daily for about three months can reduce cold or flu symptoms in children aged 4-12 who go to school or daycare. EpiCor is a supplement that may help boost the immune system.
Research Team
David Crowley, MD
Principal Investigator
KGK Science
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Run-in
Participants complete the CARIFS questionnaire and study diary during the run-in period
Treatment
Participants receive daily oral EpiCor or placebo supplementation for 84 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- EpiCor
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cargill
Lead Sponsor
KGK Science Inc.
Industry Sponsor
Najla Guthrie
KGK Science Inc.
Chief Executive Officer since 1997
Research career at the Centre for Human Nutrition, University of Western Ontario
Dr. Bibiane Zakaria
KGK Science Inc.
Chief Medical Officer since 2023
MD from an unspecified institution